Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements

A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah et al. · Pharmaceutical Research · 1995 · 5.3K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

Gerhardt Attard, Alison Reid, Timothy A. Yap et al. · Journal of Clinical Oncology · 2008 · 896 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Nanosuspensions for the formulation of poorly soluble drugs

Katrin Peters · International Journal of Pharmaceutics · 1998 · 481 citations

Pharmacy, Pharmaceutics, Pharmacology +12

Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model

Doo‐Man Oh, Rane L. Curl, Gordon L. Amidon · Pharmaceutical Research · 1993 · 247 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Design of Potent Amorphous Drug Nanoparticles for Rapid Generation of Highly Supersaturated Media

Michal E. Matteucci, Blair Brettmann, True L. Rogers et al. · Molecular Pharmaceutics · 2007 · 165 citations

Pharmacy, Materials Science, Pharmaceutics +17